Free Trial

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New $2.54 Million Investment in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 4,794 shares of the company's stock, valued at approximately $2,540,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Kestra Investment Management LLC increased its holdings in Chemed by 6.2% in the 4th quarter. Kestra Investment Management LLC now owns 1,060 shares of the company's stock worth $561,000 after purchasing an additional 62 shares in the last quarter. Venturi Wealth Management LLC increased its holdings in Chemed by 82.6% in the 4th quarter. Venturi Wealth Management LLC now owns 776 shares of the company's stock worth $411,000 after purchasing an additional 351 shares in the last quarter. CIBC Asset Management Inc increased its stake in shares of Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after buying an additional 22 shares during the period. AlphaCentric Advisors LLC acquired a new stake in shares of Chemed in the fourth quarter valued at about $520,000. Finally, Principal Financial Group Inc. increased its stake in shares of Chemed by 114.1% in the fourth quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock valued at $39,554,000 after buying an additional 39,791 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CHE. Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research note on Tuesday, November 5th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research note on Saturday, November 30th.

View Our Latest Report on CHE

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This represents a 1.93 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is owned by corporate insiders.

Chemed Price Performance

Shares of Chemed stock traded down $5.35 on Friday, hitting $544.75. 126,310 shares of the company's stock traded hands, compared to its average volume of 89,824. Chemed Co. has a one year low of $512.12 and a one year high of $654.62. The company has a fifty day moving average of $542.64 and a two-hundred day moving average of $563.96. The company has a market capitalization of $8.20 billion, a price-to-earnings ratio of 27.53, a price-to-earnings-growth ratio of 2.17 and a beta of 0.48.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.37%. Chemed's payout ratio is 10.11%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines